αααααβααΎαCSJA β’ FRA
add
Csl ADR
20.20β¬
15 ααααΆ, 1:49:42 PM ααααβααα +2 · EUR · FRA · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
DEααΆαααΈααααΆααααΆααααααΆααα
AU
αα·αααΈαα»α
19.30β¬
α
αααααααααααα
20.20β¬ - 20.20β¬
α
ααααααα½αααααΆαα
α»αααααα
19.10β¬ - 43.40β¬
ααΎαβαα»αβααΈααααΆα
67.67Β αααΈααΆα AUD
ααα ααα½αααΌαααααα
3.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 4.17Β αααΈααΆα | -1.78% |
α
αααΆαααααα·ααααα·ααΆα | 912.50Β ααΆα | -0.05% |
α
αααΌααα»ααα | 200.50Β ααΆα | -80.02% |
ααααΆααα
αααααα»ααα | 4.81 | -79.67% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 1.56Β αααΈααΆα | -2.16% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 24.74% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 1.14Β αααΈααΆα | -24.87% |
ααααααααα»α | 37.90Β αααΈααΆα | -1.42% |
ααΆαααα½ααα»αααααΌαααα»α | 17.44Β αααΈααΆα | -2.56% |
ααΌαβααααα»α | 20.46Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 482.13Β ααΆα | β |
ααααααααααΉαααααα
| 0.50 | β |
ααα
ααααααΎαααααα | 8.70% | β |
ααα
ααααααΎααΎααα»α | 10.43% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 200.50Β ααΆα | -80.02% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 651.00Β ααΆα | 3.42% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -326.00Β ααΆα | -78.14% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -821.50Β ααΆα | -70.79% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -506.00Β ααΆα | -750.42% |
ααα αΌαααΆα
αααααΆααααααα | 712.50Β ααΆα | -9.08% |
α’αααΈ
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
ααΆααααααΎαα‘αΎα
1916
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
29,904